Panamanian President Aims to Slash Medicine Prices, Marking Bold Shift in Healthcare

In a move that promises to significantly impact the lives of Panamanians, President José Raúl Mulino unveiled a sweeping plan to dramatically reduce the cost of essential medicines within the country. Announced on January 2, 2025, the initiative is set to kick off this month with a 20% discount on the most commonly prescribed drugs available in pharmacies nationwide.

President Mulino’s ambitious plan goes beyond simple price reductions. Minister of Health Fernando Boyd Galindo emphasized a commitment to creating a sustainable pharmaceutical sector in Panama, one that ensures fair profits for pharmacies while safeguarding patients from exorbitant costs.

"Our goal is not just to lower prices, but to build a system where pharmaceutical companies, pharmacies, and, most importantly, patients, all benefit fairly," stated Minister Boyd Galindo in an exclusive interview with La Prensa.

A key element of the plan involves extending the discounted prices secured by the Ministry of Health (Minsa) through public tenders to smaller pharmacies across the country. This will be achieved in collaboration with the Caja de Seguro Social (CSS), Panama’s national social security system.
Currently, smaller pharmacies face challenges in accessing the same cost-effective medicines as large providers.

According to Minister Boyd Galindo, the Minsa is working in close collaboration with various government entities, including the Medicines and Pharmacy and Drugs Directorates, to ensure this price accessibility reaches all pharmacies nationwide.

This initiative initially will focus on the 20 most commonly used medicines, with a plan to gradually expand the scope to cover a wider range of essential drugs.

Furthermore, the government is addressing deeper structural issues within the pharmaceutical sector, aiming to foster greater competition and lower prices through reformed acquisition and registration processes.

"Insufficient controls and lengthy registration processes have stifled competition in the local market," explained Minister Boyd Galindo, adding that the lack of viable alternatives contributes significantly to pharmaceutical price inflation.

In an effort to address this head-on, the Direction Nacional de Farmacia y Drogas (DNFD) is now accepting medicine registrations from countries adhering to high quality standards such as the United States and the European Union. This will facilitate the importation of more affordable, high-quality pharmaceuticals, ensuring they meet established international standards.

President Mulino’s bold move to lower medicine prices is a significant step towards improving healthcare accessibility for all Panamanians. While there are hurdles ahead in the implementation process, the collaborative efforts of the Minsa and other government entities demonstrate a clear commitment to making healthcare a fundamental right for all Panamanians. By fostering a sustainable, regulated pricing system and ensuring equitable access to essential medicines, Panama is setting an example that could resonate across the globe.